Stock comparison
Medline Inc. is 1.6x more valuable than RESMED INC by market capitalization ($49.12 B vs $30.24 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MDLN is larger
Medline Inc. is 1.6x more valuable than RESMED INC by market capitalization ($49.12 B vs $30.24 B).
Market value leader
MDLN
Medline Inc. is 1.6x more valuable than RESMED INC by market capitalization ($49.12 B vs $30.24 B).
Revenue leader
MDLN
RMD: $5.15B vs MDLN: $28.43B.
Profit leader
MDLN
RMD: $1.40B vs MDLN: $1.16T.
Margin leader
MDLN
RMD: 27.2% vs MDLN: 4069.4% net margin.
| Metric | RMD | MDLN |
|---|---|---|
| Market cap | $30.24 B | $49.12 B |
| US-listed rank | #464 | #328 |
| Revenue (latest FY) | $5.15B | $28.43B |
| Net income (latest FY) | $1.40B | $1.16T |
| Net margin | 27.2% | 4069.4% |
| P/E (trailing FY) | 21.6x | 0.0x |
| SEC filings | 2,518 | 103 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Medline Inc. is 1.6x more valuable than RESMED INC by market capitalization ($49.12 B vs $30.24 B).
In their latest fiscal years, RESMED INC reported $5.15B in revenue while Medline Inc. reported $28.43B.
Full pages: RESMED INC and Medline Inc., or browse the full rankings.